Copyright
©The Author(s) 2024.
World J Gastroenterol. Nov 14, 2024; 30(42): 4523-4531
Published online Nov 14, 2024. doi: 10.3748/wjg.v30.i42.4523
Published online Nov 14, 2024. doi: 10.3748/wjg.v30.i42.4523
Characteristics | All (n = 178) | Survivors (n = 93) | Non-survivors (n = 85) | Statistic | P value |
Age, years | 76.00 (67.00, 83.00) | 75.00 (63.00, 83.00) | 77.00 (68.00, 83.00) | Z = -1.23 | 0.218 |
Male, n (%) | 108 (60.67) | 55 (59.14) | 53 (62.35) | χ² = 0.19 | 0.661 |
Pre-existing diseases | |||||
Diabetes mellitus, n (%) | 56 (31.46) | 30 (32.26) | 26 (30.59) | χ² = 0.06 | 0.811 |
Hyptertension, n (%) | 95 (53.37) | 46 (49.46) | 49 (57.65) | χ² = 1.20 | 0.274 |
Coronary heart disease, n (%) | 40 (22.47) | 17 (18.28) | 23 (27.06) | χ² = 1.96 | 0.161 |
Stroke, n (%) | 25 (14.04) | 16 (17.20) | 9 (10.59) | χ² = 1.61 | 0.204 |
Principal pathology | |||||
Cardiovascular, n (%) | 16 (8.99) | 7 (7.53) | 9 (10.59) | χ² = 0.51 | 0.476 |
Neurological, n (%) | 16 (8.99) | 10 (10.75) | 6 (7.06) | χ² = 0.74 | 0.389 |
GI/pancreatic/liver, n (%) | 23 (12.92) | 14 (15.05) | 9 (10.59) | χ² = 0.79 | 0.375 |
Pulmonary, n (%) | 76 (42.70) | 35 (37.63) | 41 (48.24) | χ² = 2.04 | 0.153 |
Renal, n (%) | 13 (7.30) | 8 (8.60) | 5 (5.88) | χ² = 0.49 | 0.486 |
Metabolic disorders, n (%) | 6 (3.37) | 3 (3.23) | 3 (3.53) | χ² = 0.00 | > 0.999 |
Heart rate1, beats/minute | 98.47 ± 21.55 | 97.96 ± 21.65 | 99.02 ± 21.55 | t= -0.33 | 0.743 |
C-reactive protein1, mg/L | 64.63 (23.67, 138.11) | 54.43 (18.23, 144.60) | 82.74 (40.36, 132.42) | Z = -1.19 | 0.235 |
Glucose1, mmol/L | 9.31 (7.08, 13.00) | 8.97 (7.11, 12.10) | 9.42 (7.00, 14.65) | Z = -0.48 | 0.629 |
Albumin1, g/L | 28.20 (25.10, 32.03) | 28.90 (25.80, 32.90) | 27.20 (24.50, 29.30) | Z = -2.73 | 0.006 |
Serum lactate1, mmol/L | 1.70 (1.20, 2.98) | 1.60 (0.90, 2.40) | 1.90 (1.30, 3.30) | Z = -2.36 | 0.018 |
Procalcitonin1, ng/mL | 0.68 (0.20, 2.81) | 0.58 (0.18, 3.35) | 0.78 (0.29, 2.45) | Z = -0.89 | 0.373 |
Sepsis, n (%) | 43 (24.16) | 21 (22.58) | 22 (25.88) | χ² = 0.26 | 0.607 |
Abdominal surgery, n (%) | 25 (14.04) | 16 (17.20) | 9 (10.59) | χ² = 1.61 | 0.204 |
Acute kidney injure, n (%) | 93 (52.25) | 39 (41.94) | 54 (63.53) | χ² = 8.30 | 0.004 |
Mechanical ventilation, n (%) | 145 (81.46) | 63 (67.74) | 82 (96.47) | χ² = 24.27 | < 0.001 |
Start EN within 48 hours, n (%) | 138 (77.53) | 73 (78.49) | 65 (76.47) | χ² = 0.10 | 0.747 |
SOFA score2, points | 7.00 (5.00, 11.00) | 6.00 (4.00, 9.00) | 9.00 (6.00, 11.00) | Z = -4.45 | < 0.001 |
SOFA score3, points | 11.00 (7.00, 15.00) | 8.00 (6.00, 11.00) | 14.00 (11.00, 16.00) | Z = -8.28 | < 0.001 |
APACHE II score2, points | 19.00 (15.00, 24.00) | 18.00 (13.00, 22.00) | 21.00 (16.00, 25.00) | Z = -2.38 | 0.017 |
APACHE II score3, points | 22.00 (17.00, 28.00) | 18.00 (14.00, 22.00) | 26.00 (23.00, 32.00) | Z = -7.20 | < 0.001 |
AGI grade3, grade | 2.00 (2.00, 3.00) | 2.00 (1.00, 2.00) | 3.00 (2.00, 3.00) | Z = -6.85 | < 0.001 |
GIDS2, points | 1.00 (0.00, 1.00) | 1.00 (0.00, 1.00) | 1.00 (0.00, 1.00) | Z = -1.15 | 0.249 |
GIDS3, points | 2.00 (1.00, 2.00) | 1.00 (1.00, 2.00) | 2.00 (2.00, 3.00) | Z = -6.90 | < 0.001 |
Variables | Model 1 | Model 2 | ||
P value | OR (95%CI) | P value | OR (95%CI) | |
Pre-existing disease-coronary heart disease | 0.152 | 2.12 (0.76-5.92) | 0.185 | 1.99 (0.72-5.53) |
Principal pathology- Pulmonary | 0.119 | 2.05 (0.83-5.05) | 0.139 | 1.96 (0.80-4.76) |
Albumin | 0.609 | 0.98 (0.91-1.05) | 0.733 | 0.99 (0.92-1.06) |
Serum lactate | 0.316 | 0.91 (0.77-1.09) | 0.283 | 0.91 (0.76-1.08) |
Mechanical ventilation | 0.129 | 3.16 (0.72-13.95) | 0.107 | 3.37 (0.77-14.77) |
SOFA score1 | < 0.001 | 1.32 (1.13-1.54) | 0.001 | 1.29 (1.11-1.52) |
APACHE II score1 | 0.070 | 1.08 (0.99-1.18) | 0.058 | 1.09 (1.00-1.18) |
GIDS1 | 0.004 | 2.01 (1.25-3.24) | / | / |
AGI grade1 | / | / | 0.019 | 1.94 (1.12-3.38) |
Scoring system | AUC | P value | 95%CI | Cut-off value | Sensitivity (%) | Specificity (%) | YI | PV+ (%) | PV- (%) |
GIDS1 | 0.785 | < 0.001 | 0.720-0.851 | 1.5 | 87.06 | 67.74 | 0.548 | 71.15 | 85.14 |
AGI1 | 0.779 | < 0.001 | 0.713-0.845 | 2.5 | 69.41 | 84.95 | 0.544 | 80.82 | 75.24 |
SOFA1 | 0.859 | < 0.001 | 0.805-0.913 | 9.5 | 87.06 | 67.74 | 0.548 | 71.15 | 85.14 |
APACHE II1 | 0.812 | < 0.001 | 0.749-0.875 | 21.5 | 81.18 | 70.97 | 0.521 | 71.88 | 80.49 |
SOFA + GIDS2 | 0.874 | < 0.001 | 0.822-0.927 | 11.5 | 88.24 | 74.19 | 0.624 | 75.76 | 87.34 |
SOFA + AGI2 | 0.869 | < 0.001 | 0.816-0.921 | 12.5 | 85.88 | 75.27 | 0.612 | 76.04 | 85.37 |
APACHE II + GIDS2 | 0.833 | < 0.001 | 0.774-0.892 | 23.5 | 81.18 | 74.19 | 0.554 | 74.19 | 81.18 |
APACHE II + AGI2 | 0.831 | < 0.001 | 0.771-0.890 | 23.5 | 84.71 | 69.89 | 0.546 | 72.00 | 83.33 |
- Citation: Shen C, Wang X, Xiao YY, Zhang JY, Xia GL, Jiang RL. Comparing gastrointestinal dysfunction score and acute gastrointestinal injury grade for predicting short-term mortality in critically ill patients. World J Gastroenterol 2024; 30(42): 4523-4531
- URL: https://www.wjgnet.com/1007-9327/full/v30/i42/4523.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i42.4523